Yahoo Web Search

Search results

  1. For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the new breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients.

  2. Oct 18, 2023 · And that’s thanks to the revolutionary breast cancer drug Herceptin, developed by a team of scientists led by the world-renowned oncologist Dennis Slamon, MD, PhD, director of clinical and translational research at the UCLA Health Jonsson Comprehensive Cancer Center and chief of hematology/oncology at the David Geffen School of Medicine at UCLA.

  3. For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the new breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients.

    • 2336 Santa Monica Boulevard, 90404
    • (310) 998-4747
  4. Feb 16, 2024 · UCLA Health oncologist Dr. Dennis Slamon and his team brought forward Herceptin, the first FDA-approved gene-based drug to fight cancer, back in 1988. This revolutionary breast cancer drug has saved millions of lives in its 25-year history | UCLA Health

  5. Sep 9, 2019 · This year’s Lasker Clinical Research Award honors H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich for their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer. Main Text.

    • Charles L. Sawyers
    • 2019
  6. Sep 19, 2019 · This year's Lasker Clinical Research Award honors H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich for their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer.

  7. Feb 5, 2019 · Slamons research led to the development of the breast cancer drug trastuzumab (Herceptin), which since its introduction in 1998, has saved thousands of women’s lives by targeting a specific genetic alteration. The advance also helped pave the way for other targeted cancer therapies that have followed in the years since.

  8. People also ask

  1. Searches related to dennis slamon herceptin

    dr dennis slamon herceptinpat steeg
  1. People also search for